New Perspectives in the Formulary Management of Nasal Polyp Treatment: Utilization and Cost Considerations
Webinar recorded April 28, 2022
Sponsored by OptiNose
Nasal polyps remain a costly but often overlooked condition for many health plans. This webinar, sponsored by OptiNose, explores innovative strategies for analyzing medical and pharmacy costs to gain an understanding of how budgets are impacted. This though-provoking session will cover an analysis performed by Optum Insight and provide actionable intelligence to guide formulary decision making in the nasal polyp treatment category.
Michael J. Rothrock, BS, MBA, MHA
President, Allegheny Strategic Partners LLC
Ian Smith, FSA, MAAA, FCA
Actuarial Director, Pharmacy Advisory Services, Optum Insight
This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenter are those of the sponsor or presenter and not of AMCP.